Valuation : AtriCure, Inc.

Market Cap 2.77B 2.39B 2.26B 2.05B 3.85B 265B 3.87B 26.88B 10.34B 135B 10.42B 10.19B 426B P/E 2026 *
517x
P/E 2027 * 130x
Enterprise Value 2.62B 2.26B 2.14B 1.94B 3.64B 251B 3.66B 25.41B 9.77B 127B 9.85B 9.63B 403B EV / Sales 2026 *
4.33x
EV / Sales 2027 * 3.75x
Free-Float
96.23%
Yield 2026 *
-
Yield 2027 * -
1 day+2.98%
1 week+5.86%
Current month+12.80%
1 month+26.98%
3 months+91.97%
6 months+82.65%
Current year+37.87%
1 week 51.74
Extreme 51.735
55.72
1 month 43.03
Extreme 43.03
55.72
Current year 25.36
Extreme 25.36
55.72
1 year 25.36
Extreme 25.36
55.72
3 years 18.94
Extreme 18.94
55.72
5 years 18.94
Extreme 18.94
89.18
10 years 14.78
Extreme 14.78
89.18
Manager TitleAgeSince
Chief Executive Officer 55 02/11/2012
Director of Finance/CFO 48 01/07/2014
Chief Tech/Sci/R&D Officer 59 18/07/2017
Director TitleAgeSince
Director/Board Member 55 02/11/2012
Director/Board Member 64 11/03/2013
Director/Board Member 75 10/11/2016
Date Insider Type Main position Quantity % Market Cap. Importance
8/9/26 Sell

Chief Technology Officer

-3,657 0.0072%
2/9/26 Sell

Chief Technology Officer

-7,763 0.0153%
24/8/26 Sell

General Counsel

-9,370 0.0184%
Change 5-day change 1-year change 3-year change Capi.($)
+2.98%+5.86%+45.21%+26.57% 2.77B
-1.36%-5.89%-23.14%-0.49% 176B
-0.72%-3.41%-3.49%+11.74% 116B
+0.19%-2.83%+6.20%+80.93% 61.36B
-1.92%-6.01%+8.80%+41.11% 49.42B
+0.81%-3.73%-6.67%-33.43% 48.44B
-1.75%-5.54%+9.25%-22.61% 31.33B
+0.43%-11.10% - - 28.56B
+0.58%+1.84%+31.28%-12.82% 24.37B
+0.49%-7.65%-12.44%+4.86% 21.57B
Average -0.03%-3.99%+6.11%+10.65% 56.06B
Weighted average by Cap. -0.67%-4.84%-5.80%+10.93%

Financials

2026 *2027 *
Net sales 606M 522M 495M 448M 841M 57.92B 845M 5.87B 2.26B 29.47B 2.28B 2.23B 93.11B 680M 586M 554M 503M 943M 64.93B 948M 6.59B 2.53B 33.03B 2.55B 2.5B 104B
Net income 7.11M 6.13M 5.8M 5.26M 9.87M 679M 9.92M 68.91M 26.5M 346M 26.71M 26.13M 1.09B 20.78M 17.9M 16.95M 15.36M 28.82M 1.98B 28.97M 201M 77.41M 1.01B 78.03M 76.32M 3.19B
Net Debt -152M -131M -124M -112M -211M -14.53B -212M -1.47B -567M -7.39B -571M -559M -23.36B -226M -195M -185M -167M -314M -21.62B -316M -2.19B -843M -11B -850M -831M -34.76B
Logo AtriCure, Inc.
AtriCure, Inc. provides technologies for the treatment for atrial fibrillation (Afib), left atrial appendage (LAA) management and post-operative pain management. The Company's cardiac ablation and left atrial appendage management (LAAM) products are used by physicians during open-heart and minimally invasive surgical procedures. Its pain management solutions are used by physicians to freeze nerves during cardiothoracic or thoracic surgical procedures. The Company's products for open and minimally invasive ablation include Isolator Synergy Clamps and Multifunctional Pens and Linear Ablation Devices. Its products for open ablation include cryoICE Cryoablation System. Its products for minimally invasive ablation include EPi-Sense Guided Coagulation System with VisiTrax Technology. Its appendage management products include AtriClip System. The Isolator Synergy Ablation System clamps are single-use disposable radio frequency (RF) products with jaws that close in a parallel fashion.
Employees
1,350
Date Price Change Volume
11/09/26 USD 54.54 +2.98% 1,098,948
10/09/26 USD 52.96 -0.13% 961,948
09/09/26 USD 53.03 -1.30% 1,659,452
08/09/26 USD 53.73 +4.29% 1,880,277
04/09/26 USD 51.52 -1.79% 714,569
Trader
Investor
Global
Quality
ESG MSCI
A
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
10
Last Close Price
54.54USD
Average target price
51.67USD
Spread / Average Target
-5.27%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. ATRC Stock
40% Discount: Identify Tomorrow's Best Investments With The Best Subscriber-Only Tools!
d
:
:
SEIZE THE OFFER!